We are live on ! Find out more
KA

Klingman & Associates Portfolio holdings

AUM $2.35B
1-Year Est. Return 23.18%
This Fund
S&P 500
This Quarter Est. Return
+1.82%
1 Year Est. Return
+23.18%
3 Year Est. Return
+59.34%
5 Year Est. Return
+62.44%
10 Year Est. Return
+178.86%
AUM
$1.48B
AUM Growth
+$38.9M
Cap. Flow
+$63.6M
Cap. Flow %
4.29%
Top 10 Hldgs %
52.11%
Holding
255
New
19
Increased
107
Reduced
75
Closed
6

Sector Composition

Rank Sector Weight
1 Technology 6.81%
2 Financials 3.56%
3 Consumer Discretionary 1.51%
4 Healthcare 0.78%
5 Communication Services 0.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PG icon
76
Procter & Gamble
PG
$336B
$1.52M 0.1%
9,202
+624
+7% +$102K
IVOO icon
77
Vanguard S&P Mid-Cap 400 ETF
IVOO
$3.71B
$1.48M 0.1%
14,899
ABBV icon
78
AbbVie
ABBV
$443B
$1.47M 0.1%
8,596
+304
+4% +$50.4K
LLY icon
79
Eli Lilly
LLY
$1.02T
$1.43M 0.1%
1,578
+292
+23% +$234K
RWK icon
80
Invesco S&P MidCap 400 Revenue ETF
RWK
$1.31B
$1.42M 0.1%
12,954
GE icon
81
GE Aerospace
GE
$374B
$1.36M 0.09%
8,532
-2,185
-20% -$349K
VUG icon
82
Vanguard Morningstar Growth ETF
VUG
$220B
$1.3M 0.09%
20,838
+3,156
+18% +$184K
QQQ icon
83
Invesco QQQ Trust
QQQ
$453B
$1.3M 0.09%
2,711
+20
+0.7% +$8.99K
RJF icon
84
Raymond James Financial
RJF
$33.8B
$1.29M 0.09%
10,436
+27
+0.3% +$3.33K
SCHF icon
85
Schwab International Equity ETF
SCHF
$66.6B
$1.25M 0.08%
65,270
-850
-1% -$16.5K
CPNG icon
86
Coupang
CPNG
$29.3B
$1.25M 0.08%
59,571
+122
+0.2% +$2.65K
TJX icon
87
TJX Companies
TJX
$174B
$1.24M 0.08%
11,244
+193
+2% +$19.4K
VYM icon
88
Vanguard High Dividend Yield ETF
VYM
$80.9B
$1.22M 0.08%
10,277
+1,647
+19% +$195K
MRK icon
89
Merck
MRK
$322B
$1.19M 0.08%
9,594
+694
+8% +$89.4K
VIG icon
90
Vanguard Dividend Appreciation ETF
VIG
$111B
$1.18M 0.08%
6,467
+40
+0.6% +$7.2K
RWJ icon
91
Invesco S&P SmallCap 600 Revenue ETF
RWJ
$2.05B
$1.16M 0.08%
28,899
-209
-0.7% -$8.54K
ADP icon
92
Automatic Data Processing
ADP
$106B
$1.14M 0.08%
4,783
+307
+7% +$75.4K
VGSH icon
93
Vanguard Short-Term Treasury ETF
VGSH
$29.3B
$1.14M 0.08%
19,627
-433
-2% -$25K
NEE icon
94
NextEra Energy
NEE
$181B
$1.11M 0.08%
15,704
+1,242
+9% +$88.1K
VIOO icon
95
Vanguard S&P Small-Cap 600 ETF
VIOO
$4.15B
$1.07M 0.07%
10,934
IWR icon
96
iShares Russell Mid-Cap ETF
IWR
$56B
$1.02M 0.07%
12,564
+122
+1% +$9.93K
V icon
97
Visa
V
$684B
$1M 0.07%
3,817
+100
+3% +$27.4K
UBSI icon
98
United Bankshares
UBSI
$6.63B
$993K 0.07%
30,596
GBDC icon
99
Golub Capital BDC
GBDC
$3.34B
$975K 0.07%
62,050
COST icon
100
Costco
COST
$422B
$953K 0.06%
1,121
+29
+3% +$22.6K

Similar funds

Klingman & Associates's Q2 2024 Portfolio in Review

As of Q2 2024, Klingman & Associates held 255 positions worth $1.48B, up 2.7% from $1.44B the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Klingman & Associates deployed $63.6M of net new capital in Q2 2024, opening 19 new positions and adding to 107 existing holdings. Its largest new stake was iShares iBonds Dec 2027 Term Corporate ETF: 1,024,075 shares worth $24.3M.

By sector, the portfolio is most concentrated in Technology at 6.8% of assets, up from 6.1% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was FlexShares iBoxx 3-Year Target Duration TIPS Index Fund, an estimated $2.84M trimmed.

  • Klingman & Associates's largest Q2 2024 buy was iShares iBonds Dec 2027 Term Corporate ETF: 1,024,075 shares worth $24.3M.
  • Klingman & Associates added most to iShares Core S&P 500 ETF in Q2 2024, an estimated $5.65M increase.
  • Klingman & Associates's biggest Q2 2024 reduction was FlexShares iBoxx 3-Year Target Duration TIPS Index Fund, cutting an estimated $2.84M.
  • Klingman & Associates fully exited Royal Bank of Canada in Q2 2024, selling an estimated $529K.
  • Klingman & Associates's ten largest holdings make up 52% of its $1.48B portfolio in Q2 2024.
  • Klingman & Associates opened 19 new positions and closed 6 in Q2 2024.
  • Klingman & Associates's portfolio value rose 2.7% quarter-over-quarter to $1.48B.

Based on Klingman & Associates's 13F filing for Q2 2024, filed 30 Jul 2024.